Around 30 centres and hospitals in Catalonia are studying promising treatments of COVID-19


The “Corporación Catalana de Medios Audiovisuales” has published a report on the RiPCoN project, in which IRB Barcelona’s Structural Bioinformatics and Network Biology is participating. Headed by Patrick Aloy, this lab is conducting a computational study of the interactions between the coronavirus and human cells with the aim to identify drugs already on the market or under development that can tackle the spread of the virus. The goal is to identify an antiviral treatment and, in the long-term, a possible vaccine.

In addition, various media have reported on  the efforts made by IRB Barcelona to conduct mass screening for the disease.

Link to: CCMA

Link to: CCMA

Link to: La Vanguardia

Link to: ABC